JonesTrading 2023 Healthcare Summit

Title:	All About Eyes – Paradigm Shifting Therapeutic Innovations in Ophthalmology (Panel 4)

Presenter:	Ronil Patel, MS, SVP of Operations & Business Development

Ocuphire Pharma and Viatris Announce FDA Approval of RYZUMVI™ (Phentolamine Ophthalmic Solution) 0.75% Eye Drops for the Treatment of Pharmacologically-Induced Mydriasis Produced by Adrenergic Agonists (e.g., Phenylephrine) or Parasympatholytic (e.g., Tropicamide) Agents